Cite
MLA Citation
A Lindauer et al.. “Translational Pharmacokinetic/Pharmacodynamic Modeling of Tumor Growth Inhibition Supports Dose‐Range Selection of the Anti–PD‐1 Antibody Pembrolizumab.” CPT: pharmacometrics & systems pharmacology, vol. 6, 2017, pp. 11–20. http://access.bl.uk/ark:/81055/vdc_100040608213.0x000002